These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26982797)

  • 1. The "Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.
    Unzue A; Zhao H; Lolli G; Dong J; Zhu J; Zechner M; Dolbois A; Caflisch A; Nevado C
    J Med Chem; 2016 Apr; 59(7):3087-97. PubMed ID: 26982797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.
    Hay DA; Fedorov O; Martin S; Singleton DC; Tallant C; Wells C; Picaud S; Philpott M; Monteiro OP; Rogers CM; Conway SJ; Rooney TP; Tumber A; Yapp C; Filippakopoulos P; Bunnage ME; Müller S; Knapp S; Schofield CJ; Brennan PE
    J Am Chem Soc; 2014 Jul; 136(26):9308-19. PubMed ID: 24946055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain.
    Unzue A; Xu M; Dong J; Wiedmer L; Spiliotopoulos D; Caflisch A; Nevado C
    J Med Chem; 2016 Feb; 59(4):1350-6. PubMed ID: 26043365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains.
    Dalle Vedove A; Spiliotopoulos D; D'Agostino VG; Marchand JR; Unzue A; Nevado C; Lolli G; Caflisch A
    ChemMedChem; 2018 Jul; 13(14):1479-1487. PubMed ID: 29770599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics.
    Xu M; Unzue A; Dong J; Spiliotopoulos D; Nevado C; Caflisch A
    J Med Chem; 2016 Feb; 59(4):1340-9. PubMed ID: 26125948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based in silico screening of bromodomain ligands.
    Spiliotopoulos D; Caflisch A
    Drug Discov Today Technol; 2016 Mar; 19():81-90. PubMed ID: 27769362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography.
    Lolli G; Caflisch A
    ACS Chem Biol; 2016 Mar; 11(3):800-7. PubMed ID: 26942307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured water molecules in the binding site of bromodomains can be displaced by cosolvent.
    Huang D; Rossini E; Steiner S; Caflisch A
    ChemMedChem; 2014 Mar; 9(3):573-9. PubMed ID: 23804246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.
    Chen P; Chaikuad A; Bamborough P; Bantscheff M; Bountra C; Chung CW; Fedorov O; Grandi P; Jung D; Lesniak R; Lindon M; Müller S; Philpott M; Prinjha R; Rogers C; Selenski C; Tallant C; Werner T; Willson TM; Knapp S; Drewry DH
    J Med Chem; 2016 Feb; 59(4):1410-24. PubMed ID: 25799074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.
    Bennett J; Fedorov O; Tallant C; Monteiro O; Meier J; Gamble V; Savitsky P; Nunez-Alonso GA; Haendler B; Rogers C; Brennan PE; Müller S; Knapp S
    J Med Chem; 2016 Feb; 59(4):1642-7. PubMed ID: 25974391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions.
    Zhu J; Caflisch A
    J Med Chem; 2016 Jun; 59(11):5555-61. PubMed ID: 27167503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking.
    Marchand JR; Dalle Vedove A; Lolli G; Caflisch A
    J Chem Inf Model; 2017 Oct; 57(10):2584-2597. PubMed ID: 28862840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
    Fedorov O; Lingard H; Wells C; Monteiro OP; Picaud S; Keates T; Yapp C; Philpott M; Martin SJ; Felletar I; Marsden BD; Filippakopoulos P; Müller S; Knapp S; Brennan PE
    J Med Chem; 2014 Jan; 57(2):462-76. PubMed ID: 24313754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain.
    Spiliotopoulos D; Zhu J; Wamhoff EC; Deerain N; Marchand JR; Aretz J; Rademacher C; Caflisch A
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2472-2478. PubMed ID: 28410781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design.
    Duffy BC; Liu S; Martin GS; Wang R; Hsia MM; Zhao H; Guo C; Ellis M; Quinn JF; Kharenko OA; Norek K; Gesner EM; Young PR; McLure KG; Wagner GS; Lakshminarasimhan D; White A; Suto RK; Hansen HC; Kitchen DB
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2818-23. PubMed ID: 26022843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An indole-binding site is a major determinant of the ligand specificity of the GABA type A receptor-associated protein GABARAP.
    Thielmann Y; Mohrlüder J; Koenig BW; Stangler T; Hartmann R; Becker K; Höltje HD; Willbold D
    Chembiochem; 2008 Jul; 9(11):1767-75. PubMed ID: 18567048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico fragment-based drug design with SEED.
    Marchand JR; Caflisch A
    Eur J Med Chem; 2018 Aug; 156():907-917. PubMed ID: 30064119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics in drug design.
    Zhao H; Caflisch A
    Eur J Med Chem; 2015 Feb; 91():4-14. PubMed ID: 25108504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the protein-ligand interaction energy for model building and validation.
    Beshnova DA; Pereira J; Lamzin VS
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):195-202. PubMed ID: 28291754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.